Value investing is built on buying companies whose market price is lower than their intrinsic value, but identifying such opportunities requires a discipline that goes beyond a single valuation metric. The Decent Value screen applies exactly that discipline, looking for stocks with strong valuation scores while still requiring decent profitability, financial health, and growth. TENET HEALTHCARE CORP (NYSE:THC) stands out as a candidate under this methodology, trading at a notable discount to its industry peers while maintaining strong profit generation.
Valuation: A Clear Discount to the Market
Tenet's valuation is among the more attractive in the Health Care Providers & Services industry. The stock carries a P/E ratio of 13.27, making it cheaper than 88.12% of its industry peers and well below the S&P 500 average of 26.22. Forward earnings tell a similar story: the Price/Forward Earnings ratio sits at 13.44, below 81.19% of the industry, while the EV/EBITDA and Price/Free Cash Flow multiples are cheaper than 88.12% and 93.07% of peers, respectively. A low PEG ratio further suggests the market is not fully compensating for the company's growth potential.
Investors who want to examine the full set of underlying metrics can review the fundamental analysis report for a detailed breakdown.
Profitability: Quality Behind the Discount
What makes Tenet interesting for value investors is that the cheap valuation is not a reflection of weak operations. The company earns a profitability rating of 9 out of 10, placing it among the strongest in its peer group.
- Return on Equity: 48.11%, outperforming 97.03% of industry peers
- Return on Invested Capital: 12.43%, outperforming 88.12% of peers
- Return on Assets: 7.31%, outperforming 85.15% of peers
- Operating Margin: 17.67%, outperforming 96.04% of peers
- Profit Margin: 10.27%, outperforming 93.07% of peers
The combination of cheap multiples and high profitability is precisely what value investors look for; it suggests the market may be underpricing the company's earnings power rather than discounting a broken business.
Health and Growth: Acceptable Trade-Offs
The overall fundamental rating of 6 out of 10 reflects some compromises. The health score of 5 out of 10 points to leverage concerns: the Debt/Equity ratio of 2.81 is worse than 75.25% of the industry, and the Altman-Z score of 1.96 places the company in a grey zone. However, the current ratio of 1.41 and quick ratio of 1.35 indicate adequate short-term liquidity, and management has reduced both the share count and the debt-to-assets ratio over the past year.
Growth is moderate but positive. Earnings per share rose 31.12% over the past year and have grown at an average annual pace of 16.26%, while revenue increased 5.43% last year. Forward estimates point to slower EPS growth of around 3.56% per year, which tempers the growth rating to 4 out of 10, but the trajectory still supports the case for a company compounding value over time.
Why This Matters for the Value Strategy
The Decent Value screen exists to separate genuine opportunities from value traps. A low P/E alone can hide deteriorating fundamentals, so the screen requires that valuation strength be paired with acceptable profitability, health, and growth. Tenet passes that test: its margins are excellent, its liquidity is sound, and its leverage, while elevated, is being managed down. The margin of safety for value investors comes from the gap between the market's modest pricing and the company's demonstrated earnings quality.
For investors who want to find more stocks that match this methodology, this screen overview lists additional companies that combine attractive valuations with decent fundamentals.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Tenet Healthcare (NYSE:THC): Undervalued With Strong Profitability
Value investing is built on buying companies whose market price is lower than their intrinsic value, but identifying such opportunities requires a discipline that goes beyond a single valuation metric. The Decent Value screen applies exactly that discipline, looking for stocks with strong valuation scores while still requiring decent profitability, financial health, and growth. TENET HEALTHCARE CORP (NYSE:THC) stands out as a candidate under this methodology, trading at a notable discount to its industry peers while maintaining strong profit generation.
Valuation: A Clear Discount to the Market
Tenet's valuation is among the more attractive in the Health Care Providers & Services industry. The stock carries a P/E ratio of 13.27, making it cheaper than 88.12% of its industry peers and well below the S&P 500 average of 26.22. Forward earnings tell a similar story: the Price/Forward Earnings ratio sits at 13.44, below 81.19% of the industry, while the EV/EBITDA and Price/Free Cash Flow multiples are cheaper than 88.12% and 93.07% of peers, respectively. A low PEG ratio further suggests the market is not fully compensating for the company's growth potential.
Investors who want to examine the full set of underlying metrics can review the fundamental analysis report for a detailed breakdown.
Profitability: Quality Behind the Discount
What makes Tenet interesting for value investors is that the cheap valuation is not a reflection of weak operations. The company earns a profitability rating of 9 out of 10, placing it among the strongest in its peer group.
The combination of cheap multiples and high profitability is precisely what value investors look for; it suggests the market may be underpricing the company's earnings power rather than discounting a broken business.
Health and Growth: Acceptable Trade-Offs
The overall fundamental rating of 6 out of 10 reflects some compromises. The health score of 5 out of 10 points to leverage concerns: the Debt/Equity ratio of 2.81 is worse than 75.25% of the industry, and the Altman-Z score of 1.96 places the company in a grey zone. However, the current ratio of 1.41 and quick ratio of 1.35 indicate adequate short-term liquidity, and management has reduced both the share count and the debt-to-assets ratio over the past year.
Growth is moderate but positive. Earnings per share rose 31.12% over the past year and have grown at an average annual pace of 16.26%, while revenue increased 5.43% last year. Forward estimates point to slower EPS growth of around 3.56% per year, which tempers the growth rating to 4 out of 10, but the trajectory still supports the case for a company compounding value over time.
Why This Matters for the Value Strategy
The Decent Value screen exists to separate genuine opportunities from value traps. A low P/E alone can hide deteriorating fundamentals, so the screen requires that valuation strength be paired with acceptable profitability, health, and growth. Tenet passes that test: its margins are excellent, its liquidity is sound, and its leverage, while elevated, is being managed down. The margin of safety for value investors comes from the gap between the market's modest pricing and the company's demonstrated earnings quality.
For investors who want to find more stocks that match this methodology, this screen overview lists additional companies that combine attractive valuations with decent fundamentals.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »